Clinical Trial

Effects of Huperzine a on Presbycusis(Δ,kHz, DB,MMSE, AD)

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
To investigate the effects of huperzine A on tinnitus suppression, hearing and cognitive function protection in patients with presbycusis-related subjective tinnitus and cognitive impairment.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2017-04-04; most recent amendment 2024-09-28.
Status change: Recruiting → Enrolling by Invitation 2018-07-31
Status change: Not Yet Recruiting → Recruiting 2017-07-30
Trial Details
NCT Number NCT03101722
Lead Sponsor Zhijun Bao
Conditions Presbycusis, Tinnitus, Cognitive Impairment
Enrollment 60 participants
Start Date 2017-05-15
Primary Completion 2030-09-15 (estimated)
Study Completion 2030-09-15 (estimated)
Updated on ClinicalTrials.gov 2024-10-01